Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / CCL15

CCL15

Basics

Aliases:
This biomarker is also known as:
  • MIP-1d,
  • Leukotactin-1,
  • small inducible cytokine subfamily A (Cys-Cys), member 15,
  • new CC chemokine 3,
  • NCC-3,
  • chemokine (C-C motif) ligand 15,
  • NCC3,
  • MIP-1D,
  • LKN1,
  • MIP-5,
  • SCYL3,
  • C-C motif chemokine 15,
  • HCC-2,
  • Lkn-1,
  • macrophage inflammatory protein 5,
  • small-inducible cytokine A15,
  • Macrophage inflammatory protein 5,
  • leukotactin 1,
  • MRP-2B,
  • HMRP-2B,
  • Chemokine CC-2,
  • chemokine CC-2,
  • LKN-1,
  • MIP-1 delta,
  • MIP5,
  • SY15,
  • SCYA15,
  • Small-inducible cytokine A15,
  • Mrp-2b,

View in BioMuta

Description…

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: CCL15

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.